Keyence (6861) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
27 Apr, 2026Executive summary
Net sales increased by 10.4% year-over-year to ¥1,169.3 billion for FY2025, with net income attributable to owners rising 11.7% to ¥445.2 billion.
Operating income rose 8.4% year-over-year to ¥595.8 billion.
Comprehensive income surged 23.8% year-over-year to ¥472,068 million.
Fourth quarter saw accelerated growth, with net sales up 17.9% and net income up 25.4% year-over-year.
Earnings per share increased to ¥1,835.63 from ¥1,643.77 year-over-year.
Financial highlights
Gross profit reached ¥970,737 million, up from ¥887,700 million year-over-year.
Operating margin was 51.0%, slightly down from 51.9% the previous year.
FY2025 4Q operating income margin remained strong at 53.6%.
Gross margin held steady at 83.5% in 4Q, matching the previous year.
Total assets grew to ¥3,670,655 million from ¥3,289,224 million year-over-year.
Outlook and guidance
Focus on sustainable growth through investments in new product development, overseas expansion, and business infrastructure.
Strategic M&A and human capital investment prioritized for medium- to long-term value creation.
Annual dividend forecast for the year ending March 20, 2027 is ¥550.00 per share.
Stable dividends and flexible share repurchases to continue.
Management notes forecasts are based on current information and reasonable assumptions, with actual results potentially differing.
Latest events from Keyence
- Double-digit profit growth and strong margins, aided by favorable exchange rates.6861
Q1 20253 Aug 2026 - Net sales and operating income rose over 10% year-over-year, with gross margin at 84.2%.6861
Q2 20253 Aug 2026 - Net sales and net income rose over 9% year-over-year, with a higher annual dividend forecast.6861
Q3 20253 Aug 2026 - Strong sales and profit growth, higher dividends, and robust overseas demand supported by FX gains.6861
Q4 20253 Aug 2026 - Sales and operating income rose, but net income fell 1.5% as R&D and capex increased.6861
Q1 20263 Aug 2026 - Net sales and net income soared year-over-year, with robust margins and stable dividend guidance.6861
Q1 202729 Jul 2026 - Strong sales and profit growth, driven by overseas markets and higher dividends.6861
Q3 202630 Jan 2026 - Net sales, net income, and dividends rose, with comprehensive income up 17.2%.6861
Q2 202630 Oct 2025